Pal Aukrust
Overview
Explore the profile of Pal Aukrust including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
669
Citations
13437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heldal T, Asberg A, Ueland T, Reisaeter A, Pischke S, Mollnes T, et al.
Front Immunol
. 2025 Mar;
16:1529812.
PMID: 40046053
Background: An inflammatory environment following kidney transplantation is associated with increased risk of graft loss and mortality, however, evaluation of systemic inflammation is not implemented in structured risk assessment in...
2.
Svedlund Eriksson E, Lantero Rodriguez M, Halvorsen B, Johansson I, Martensson A, Wilhelmson A, et al.
Nat Commun
. 2025 Feb;
16(1):1142.
PMID: 39910039
Men develop larger infarct sizes than women after a myocardial infarction (MI), but the mechanism underlying this sex difference is unknown. Here, we demonstrated that blood neutrophil counts post-MI were...
3.
Nilsen D, Aarsetoey R, Poenitz V, Ueland T, Aukrust P, Michelsen A, et al.
Int J Cardiol Heart Vasc
. 2025 Feb;
56:101600.
PMID: 39897419
Background: α1-antichymotrypsin (SERPINA3), high sensitivity C-reactive protein (hsCRP) and pentraxin 3 (PTX3) are acute phase proteins triggered by inflammation, whereas D-dimer, fibrin monomer and α2-antiplasmin are thrombo-fibrinolytic markers. Sex differences...
4.
Louwe M, Gialeli C, Michelsen A, Holm S, Edsfeldt A, Skagen K, et al.
J Am Heart Assoc
. 2025 Jan;
14(3):e038316.
PMID: 39868499
Background: Complement activation may promote atherosclerosis. Yet, data on the to which extent complement, and more specifically the alternative complement pathway, is activated in patients with carotid atherosclerosis and related...
5.
Lauritzen K, Yang K, Frisk M, Louwe M, Olsen M, Ziegler M, et al.
Front Immunol
. 2025 Jan;
15():1497984.
PMID: 39840045
Introduction: CD38, a regulator of intracellular calcium signalling, is highly expressed in immune cells. Mice lacking CD38 are very susceptible to acute bacterial infections, implicating CD38 in innate immune responses....
6.
Saeed S, Eriksen E, Aukrust P, Halvorsen B, Loland K, Bleie O, et al.
Coron Artery Dis
. 2025 Jan;
PMID: 39829382
No abstract available.
7.
Edvardsen M, Hansen E, Ueland T, Latysheva N, Aukrust P, Snir O, et al.
Res Pract Thromb Haemost
. 2025 Jan;
9(1):102636.
PMID: 39810988
Background: A high level of plasma coagulation factor (F)VIII is an established and likely causal risk factor for venous thromboembolism (VTE). Procoagulant phospholipids (PPLs) facilitate FVIII activity in coagulation. Objectives:...
8.
Viermyr H, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas J, et al.
EBioMedicine
. 2024 Dec;
111():105511.
PMID: 39731852
Background: The Bari-SolidAct randomized controlled trial compared baricitinib with placebo in patients with severe COVID-19. A post hoc analysis revealed a higher incidence of serious adverse events (SAEs) among SARS-CoV-2-vaccinated...
9.
Grannes H, Sharma A, Suntharalingam A, Michelsen A, Aukrust P, Ueland T, et al.
Heliyon
. 2024 Dec;
10(22):e40339.
PMID: 39641064
Background: Women with South Asian ethnicity have a higher risk of developing type 2 diabetes mellitus (T2DM) compared with white women of European descent, especially after gestational diabetes mellitus (GDM)....
10.
Patrick-Brown T, Barratt-Due A, Troseid M, Dyrhol-Riise A, Nezvalova-Henriksen K, Kasine T, et al.
Commun Med (Lond)
. 2024 Nov;
4(1):231.
PMID: 39533001
Background: There is an unmet need for treatment of long-term symptoms following COVID-19. Remdesivir is currently the only antiviral approved by the European Medicines Agency for hospitalised patients. Here, we...